Insights
Insights From Our Experts
Articles
WEBINAR: Innovative Pharmacy and Distribution Models Driven by Market Dynamics, Product Type, Site of Care and Reimbursement
The landscape of the pharmaceutical distribution industry is shifting from a familiar state to a novel market calling for a new level of channel service due to forces of innovation. In this webinar, EVERSANA’s Scot Buchanan,…
How to Ensure Speed and Efficiency When Launching in Europe
Today is an extraordinary time for medical innovation. The pharmaceutical industry is yielding protection against diseases, focusing more on rare and complex disease treatments, and the world is getting better health outcomes. Global life expectancy is…
Reversing the Complexity of Oncology Commercialization: How to solve for launch challenges in a chaotic ecosystem
As physicians, patients and caregivers tirelessly fight complex diseases, a growing number of drug manufacturers are preparing to launch new oncology therapies. These high-science therapies are entering the market at rapid rates: Presently, there are 500…
A Holistic Launch in Europe Is Possible, But Change Is Necessary
Unless you live in Europe or have commercialized a product in this region, you may not realize that the European pharmaceutical market is a huge contributor to global health, and it is currently undergoing market-wide changes.…
How to Eliminate Access, Affordability and Adherence Barriers in 2022
Today, everyone expects both digital and human outreach, and manufacturers face the challenge of trying to strike the right balance between tech and in-person touchpoints to enhance patient and healthcare provider (HCP) engagement. Despite all the…
A Partnership Q&A with EVERSANA and Shorla Pharma
As industry and patient needs progress beyond traditional commercialization models, new models are needed to deliver products to patients quicker, especially when launching in international markets. Still asking yourself how to execute on a global pharmaceutical product launch? EVERSANA has the answer to this question and others that you’ll have…
QUIZ: How Mature Are Your HCP & Patient Engagement Strategies?
In the increasingly virtual world we live in, there’s no denying the instrumental role that technology plays in engaging patients and healthcare providers (HCPs). With heavier reliance across industries on text alerts, automated phone reminders and…
A YEAR OF ACTION: Why Data-Backed, Integrated Commercialization Strategies Are Must-haves in 2022
By applying transformative commercialization models, nurturing digital transformation and trailblazing in global expansion, we can get therapies to patients around the world who are still waiting for treatment options. For the past two years, the pharmaceutical…
The Power to Know When: Balancing High-Tech and High-Touch Solutions to Eliminate Access, Affordability and Adherence Barriers
Forty percent of consumers prefer speaking to a real person on the phone, and for more complex issues, 80% want to speak to a live service agent. In the increasingly virtual world we live in, one…
Why Launching in Europe Is Unlike Launching Anywhere Else
Today, there are more than half a billion people in the European Union (EU) and United Kingdom (U.K.). Passing over this part of the globe puts patients and manufacturers at risk for negative outcomes. Launching a…